πŸ‡ΊπŸ‡Έ FDA
Patent

US 9499487

Neprilysin inhibitors

granted A61KA61K31/4196A61K31/42

Quick answer

US patent 9499487 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/4196, A61K31/42, A61K31/4355, A61K31/437